Ignite Creation Date:
2024-05-06 @ 1:50 PM
Last Modification Date:
2024-10-26 @ 1:21 PM
Study NCT ID:
NCT04146571
Status:
AVAILABLE
Last Update Posted:
2022-10-20
First Post:
2019-10-28
Brief Title:
Expanded Access to Ensartinib for Participants With ALK NSCLC
Sponsor:
Xcovery Holdings Inc
Organization:
Xcovery Holdings Inc